David K. Hooper, MD, MS

My Biography & Research

Biography

Jointly appointed in the Division of Nephrology and Hypertension and the James M. Anderson Center for Health Systems Excellence at Cincinnati Children’s Hospital Medical Center within the UC Department of Pediatrics, Dr. Hooper's aim is to improve clinical outcomes for pediatric kidney transplant recipients through research in personalized care and the design of reliable healthcare systems.

Dr. Hooper's research training includes a master's degree in clinical and translational research from the University of Cincinnati, in addition to advanced training in quality improvement methodology through the Quality Scholars in Healthcare Transformation program at Cincinnati Children’s.

Dr. Hooper founded and leads the Improving Renal Outcomes Collaborative, a learning health network of 25 kidney transplant programs nationally focused on combining clinical outcomes research with quality improvement to partner with patients and their caregivers to achieve health, longevity and quality of life equivalent to the general population.

Additional Languages

Russian

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Departments

Nephrology and Hypertension, Kidney Transplant, Dialysis, End-Stage Renal Disease, Colorectal Disorders, Nephrology and Hypertension

My Locations

Anderson

Anderson

7495 State Road

Suite 355

Cincinnati, Ohio 45255

1-513-636-6100

Directions From

My Education

MD: University of Utah, Salt Lake City, Utah, 2003.

Residency: Cincinnati Children's Hospital, Cincinnati, Ohio, 2006.

Chief Residency: Cincinnati Children's Hospital, Cincinnati, Ohio, 2007.

MS: University of Cincinnati, Cincinnati, Ohio, 2010.

Fellowship: Cincinnati Children's Hospital, Cincinnati Ohio, 2010; Quality Scholar in Healthcare Transformation, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital, Cincinnati, Ohio, 2011.

Certification: Pediatrics, 2006.

My Publications

Is anuria prior to pediatric renal transplantation associated with poor allograft outcomes?. Alam, Z; VanderBrink, BA; Brewer, N; Hooper, D; Tiao, G; Alonso, M; Nathan, J; DeFoor, WR; Sheldon, C; Reddy, PP. Pediatric Transplantation. 2019; 23.

Health-related quality of life in glomerular disease. Canetta, PA; Troost, JP; Mahoney, S; Kogon, AJ; Carlozzi, N; Bartosh, SM; Cai, Y; Davis, TK; Fernandez, H; Fornoni, A; et al. Kidney International. 2019; 95:1209-1224.

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. Mariani, LH; Bomback, AS; Canetta, PA; Flessner, MF; Helmuth, M; Hladunewich, MA; Hogan, JJ; Kiryluk, K; Nachman, PH; Nast, CC; et al. American Journal of Kidney Diseases. 2019; 73:218-229.

Quality initiatives in pediatric transplantation. Kelly, B; Squires, JE; Feingold, B; Hooper, DK; Mazariegos, GV. Current Opinion in Organ Transplantation. 2019; 24:64-72.

Composite Health Outcomes in Pediatric and Young Adult Kidney Transplant Recipients. Taylor, VA; Kirby, CL; Nehus, EJ; Goebel, J; Hooper, DK. The Journal of Pediatrics. 2019; 204:196-202.

IGG3 anti-HLA donor-specific antibodies and graft function in pediatric kidney transplant recipients. Hamdani, G; Goebel, JW; Brailey, P; Portwood, EA; Hooper, DK; Girnita, AL. Pediatric Transplantation. 2018; 22:e13219-e13219.

Predicting health care utilization and charges using a risk score for poor adherence in pediatric kidney transplant recipients. Rich, KL; Modi, AC; Mara, C; Pai, AL H; Varnell, CD; Turnier, L; Huber, J; Hooper, DK. Clinical Practice in Pediatric Psychology. 2018; 6:107-116.

Durability of the hepatitis B vaccination in pediatric renal transplant recipients. Miller-Handley, H; Paulsen, G; Hooper, DK; Lake, M; Lazear, D; Danziger-Isakov, L. Clinical Transplantation. 2018; 32:e13247-e13247.

Assessing barriers to adherence in routine clinical care for pediatric kidney transplant patients. Jr, VC D; Rich, KL; Nichols, M; Dahale, D; Goebel, JW; Pai, AL H; Hooper, DK; Modi, AC. Pediatric Transplantation. 2017; 21:e13027-e13027.

Mycophenolate mofetil-related leukopenia in children and young adults following kidney transplantation: Influence of genes and drugs. Varnell, CD; Fukuda, T; Kirby, CL; Martin, LJ; Warshaw, BL; Patel, HP; Chand, DH; Barletta, G; Van Why, SK; VanDeVoorde, RG; et al. Pediatric Transplantation. 2017; 21:e13033-e13033.